The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study
dc.contributor.author | Fossum, E. | en_US |
dc.contributor.author | Gleim, G. W. | en_US |
dc.contributor.author | Kjeldsen, Sverre E. | en_US |
dc.contributor.author | Kizer, Jorge R. | en_US |
dc.contributor.author | Julius, Stevo | en_US |
dc.contributor.author | Devereux, Richard B. | en_US |
dc.contributor.author | Brady, W. E. | en_US |
dc.contributor.author | Hille, D. A. | en_US |
dc.contributor.author | Lydic, Ralph | en_US |
dc.contributor.author | Dahlöf, B. | en_US |
dc.date.accessioned | 2010-06-01T21:31:47Z | |
dc.date.available | 2010-06-01T21:31:47Z | |
dc.date.issued | 2007-10 | en_US |
dc.identifier.citation | Fossum, E.; Gleim, G. W.; Kjeldsen, S. E.; Kizer, J. R.; Julius, S.; Devereux, R. B.; Brady, W. E.; Hille, D. A.; Lyle, P. A.; DahlÖf, B. (2007). "The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study." Journal of Internal Medicine 262(4): 439-448. <http://hdl.handle.net/2027.42/74584> | en_US |
dc.identifier.issn | 0954-6820 | en_US |
dc.identifier.issn | 1365-2796 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74584 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17875180&dopt=citation | en_US |
dc.format.extent | 672535 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2007 Blackwell Publishing Ltd | en_US |
dc.subject.other | Atenolol | en_US |
dc.subject.other | Cardiovascular Risk | en_US |
dc.subject.other | Exercise | en_US |
dc.subject.other | LIFE Study | en_US |
dc.subject.other | Losartan | en_US |
dc.subject.other | Physical Activity | en_US |
dc.subject.other | Type 2 Diabetes | en_US |
dc.title | The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, MI ; | en_US |
dc.contributor.affiliationother | Ullevaal University Hospital, University of Oslo, Oslo, Norway ; | en_US |
dc.contributor.affiliationother | Merck Research Laboratories, West Point, PA ; | en_US |
dc.contributor.affiliationother | Weill Medical College of Cornell University, New York, NY, USA , and | en_US |
dc.contributor.affiliationother | Sahlgrenska University Hospital/Östra, GÖteborg, Sweden | en_US |
dc.identifier.pmid | 17875180 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74584/1/j.1365-2796.2007.01808.x.pdf | |
dc.identifier.doi | 10.1111/j.1365-2796.2007.01808.x | en_US |
dc.identifier.source | Journal of Internal Medicine | en_US |
dc.identifier.citedreference | Pate RR, Pratt M, Blair SN et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402 – 7. | en_US |
dc.identifier.citedreference | American Heart Association. Heart Disease and Stroke Statistics – 2005 Update. Dallas, TX: American Heart Association, 2005. | en_US |
dc.identifier.citedreference | Thompson PD, Buchner D, PiÑa IL et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107: 3109 – 16. | en_US |
dc.identifier.citedreference | Ekelund LG, Haskell WL, Johnson JL et al. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-Up Study. N Engl J Med 1988; 319: 1379 – 84. | en_US |
dc.identifier.citedreference | Lee IM, Sesso HD, Oguma Y, Paffenbarger RS Jr. Relative intensity of physical activity and risk of coronary heart disease. Circulation 2003; 107: 1110 – 6. | en_US |
dc.identifier.citedreference | Lee IM, Sesso HD, Paffenbarger RS Jr. Physical activity and coronary heart disease risk in men: does duration of exercise episodes predict risk? Circulation 2000; 102: 981 – 6. | en_US |
dc.identifier.citedreference | Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993; 328: 533 – 7. | en_US |
dc.identifier.citedreference | Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke 2003; 34: 2475 – 81. | en_US |
dc.identifier.citedreference | Lee CD, Blair SN. Cardiorespiratory fitness and stroke mortality in men. Med Sci Sports Exerc 2002; 34: 592 – 5. | en_US |
dc.identifier.citedreference | Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793 – 801. | en_US |
dc.identifier.citedreference | Paffenbarger RS Jr, Hyde RT, Wing AL, Lee IM, Jung DL, Kampert JB. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993; 328: 538 – 45. | en_US |
dc.identifier.citedreference | Blair SN, Kampert JB, Kohl HW III et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996; 276: 205 – 10. | en_US |
dc.identifier.citedreference | Farrell SW, Kampert JB, Kohl HW III et al. Influences of cardiorespiratory fitness levels and other predictors on cardiovascular disease mortality in men. Med Sci Sports Exerc 1998; 30: 899 – 905. | en_US |
dc.identifier.citedreference | Oguma Y, Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and all cause mortality in women: a review of the evidence. Br J Sports Med 2002; 36: 162 – 72. | en_US |
dc.identifier.citedreference | Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989; 262: 2395 – 401. | en_US |
dc.identifier.citedreference | Blair SN, Kohl HW III, Barlow CE, Gibbons LW. Physical fitness and all-cause mortality in hypertensive men. Ann Med 1991; 23: 307 – 12. | en_US |
dc.identifier.citedreference | DahlÖf B, Devereux R, de Faire U et al. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension Study: rationale, design, and methods. Am J Hypertens 1997; 10: 705 – 13. | en_US |
dc.identifier.citedreference | DahlÖf B, Devereux RB, Julius S et al. Characteristics of 9194 patients with left ventricular hypertrophy. The LIFE study. Losartan Intervention For Endpoint reduction in hypertension. Hypertension 1998; 32: 989 – 97. | en_US |
dc.identifier.citedreference | DahlÖf B, Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 995 – 1003. | en_US |
dc.identifier.citedreference | WHO Study Group. Diabetes Mellitus (technical report series 727). Geneva: WHO, 1985. | en_US |
dc.identifier.citedreference | Lindholm LH, Ibsen H, Borch-Johnsen K et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 2002; 20: 1879 – 86. | en_US |
dc.identifier.citedreference | Anderson KM, Wilson PWF, Odell PM et al. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356 – 62. | en_US |
dc.identifier.citedreference | Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36: 533 – 53. | en_US |
dc.identifier.citedreference | Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 1984; 252: 487 – 90. | en_US |
dc.identifier.citedreference | Ishikawa-Takata K, Ohta T, Tanaka H. How much exercise is required to reduce blood pressure in essential hypertensives: a dose–response study. Am J Hypertens 2003; 16: 629 – 33. | en_US |
dc.identifier.citedreference | Manson JE, Hu FB, Rich-Edwards JW et al. A prospective study of walking compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 1999; 341: 650 – 8. | en_US |
dc.identifier.citedreference | Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation 2000; 102: 975 – 80. | en_US |
dc.identifier.citedreference | Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 2005; 36: 1994 – 9. | en_US |
dc.identifier.citedreference | Lee IM, Paffenbarger RS Jr. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke 1998; 29: 2049 – 54. | en_US |
dc.identifier.citedreference | Rodriguez CJ, Sacco RL, Sciacca RR, Boden-Albala B, Homma S, Di Tullio MR. Physical activity attenuates the effect of increased left ventricular mass on the risk of ischemic stroke: the Northern Manhattan Stroke Study. J Am Coll Cardiol 2002; 39: 1482 – 8. | en_US |
dc.identifier.citedreference | Lee IM, Hsieh CC, Paffenbarger RS Jr. Exercise intensity and longevity in men. The Harvard Alumni Health Study. JAMA 1995; 273: 1179 – 84. | en_US |
dc.identifier.citedreference | Lee IM, Paffenarger RS Jr. Associations of light, moderate, and vigorous intensity physical activity with longevity. The Harvard Alumni Health Study. Am J Epidemiol 2000; 151: 293 – 9. | en_US |
dc.identifier.citedreference | Church TS, Kampert JB, Gibbons LW, Barlow CE, Blair SN. Usefulness of cardiorespiratory fitness as a predictor of all-cause and cardiovascular disease mortality in men with systemic hypertension. Am J Cardiol 2001; 88: 651 – 6. | en_US |
dc.identifier.citedreference | Crespo CJ, Palmieri MR, Perdomo RP et al. The relationship of physical activity and body weight with all-cause mortality: results from the Puerto Rico Heart Health Program. Ann Epidemiol 2002; 12: 543 – 52. | en_US |
dc.identifier.citedreference | Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995; 273: 1093 – 8. | en_US |
dc.identifier.citedreference | Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325: 147 – 52. | en_US |
dc.identifier.citedreference | Ivy JL. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus. Sports Med 1997; 24: 321 – 36. | en_US |
dc.identifier.citedreference | Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393 – 403. | en_US |
dc.identifier.citedreference | Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation 2003; 107: 2435 – 9. | en_US |
dc.identifier.citedreference | Albright A, Franz M, Hornsby G et al. American College of Sports Medicine position stand. Exercise and type 2 diabetes. Med Sci Sports Exerc 2000; 32: 1345 – 60. | en_US |
dc.identifier.citedreference | Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343 – 50. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.